Ad is loading...
CFXRX
Price
$14.57
Change
+$0.10 (+0.69%)
Updated
Nov 22 closing price
JABLX
Price
$52.16
Change
+$0.03 (+0.06%)
Updated
Nov 22 closing price
Ad is loading...

CFXRX vs JABLX

Header iconCFXRX vs JABLX Comparison
Open Charts CFXRX vs JABLXBanner chart's image
Columbia Flexible Capital Income Inst2
Price$14.57
Change+$0.10 (+0.69%)
VolumeN/A
CapitalizationN/A
Janus Henderson VIT Balanced Instl
Price$52.16
Change+$0.03 (+0.06%)
VolumeN/A
CapitalizationN/A
CFXRX vs JABLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CFXRX vs. JABLX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CFXRX is a StrongBuy and JABLX is a Buy.

FUNDAMENTALS
Fundamentals
JABLX has more cash in the bank: 9.07B vs. CFXRX (1.26B). CFXRX pays higher dividends than JABLX: CFXRX (5.42) vs JABLX (1.87). CFXRX was incepted earlier than JABLX: CFXRX (12 years) vs JABLX (31 years). JABLX is a more actively managed with annual turnover of: 97.00 vs. CFXRX (44.00). CFXRX (0) and JABLX (0) have matching initial minimum investment requirements. CFXRX (21.49) and JABLX (21.08) have marching annual gain over last year. JABLX return over 5 years is better than : 45.48 vs. CFXRX (36.19).
CFXRXJABLXCFXRX / JABLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years31 years-
Gain YTD13.48916.26483%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.26B9.07B14%
Annual Yield % from dividends5.421.87289%
Returns for 1 year21.4921.08102%
Returns for 3 years5.209.8953%
Returns for 5 years36.1945.4880%
Returns for 10 years72.6495.1476%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SCKT1.480.03
+2.07%
Socket Mobile
AVA39.040.52
+1.35%
Avista Corp
PWOD30.130.29
+0.97%
Penns Woods Bancorp
KIM25.310.22
+0.88%
Kimco Realty Corp
TRDA18.050.12
+0.67%
Entrada Therapeutics